Clinical Trial Update: Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study in healthy volunteers evaluating safety, tolerability, and pharmacokinetics of XC221 has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Infection

Drugs mentioned

• XC221

Snippet

Sponsor: PHARMENTERPRISES LLC | Conditions: Influenza, Acute Respiratory Infection | Phase 1 | Status: COMPLETED